Results 111 to 119 of about 233 (119)

Limitation of Eye Movement in Merosin-Deficient Congenital Muscular Dystrophy

Lancet, The, 1999
Francesco Muntoni, J Philpot
exaly  

Exon Skipping and Dystrophin Restoration in Patients With Duchenne Muscular Dystrophy After Systemic Phosphorodiamidate Morpholino Oligomer Treatment: An Open-Label, Phase 2, Dose-Escalation Study

Lancet, The, 2011
Virginia Arechavala-Gomeza, Dominic J Wells, Karen Anthony   +2 more
exaly  

Prednisone in Duchenne Muscular Dystrophy.

Lancet, The, 1974
K V Toyka, K V Toyka
exaly  

Efficacy of Idebenone on Respiratory Function in Patients With Duchenne Muscular Dystrophy Not Using Glucocorticoids (DELOS): A Double-Blind Randomised Placebo-Controlled Phase 3 Trial

Lancet, The, 2015
Thomas Voit, Craig M. McDonald, Richard Finkel   +2 more
exaly  

The Importance of Muscular Strength in Athletic Performance

Sports Medicine, 2016
Timothy J Suchomel, Sophia Nimphius
exaly  

The FDA and Gene Therapy for Duchenne Muscular Dystrophy

JAMA - Journal of the American Medical Association
David M Rind
exaly  

Spending on Targeted Therapies for Duchenne Muscular Dystrophy

JAMA - Journal of the American Medical Association
Benjamin N Rome, Aaron Seth Kesselheim
exaly  

Muscular Dystrophy: New Treatments, New Hopes

Lancet, The, 2019
exaly  

Muscular Dystrophy

JAMA - Journal of the American Medical Association, 2011
exaly